
													
															
															Year
															DEALS // DEV.
															Country
															
															Therapeutic Area
															Study Phase
															Deal Type
															Product Type
															Dosage Form
															Lead Product
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : RQM+ | Dabl Ltd | Medical Labs Memphis - MLM
Deal Size : Inapplicable
Deal Type : Inapplicable
Renal Pelvic Denervation Pilot Trial
Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Hypertension.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 04, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : RQM+ | Dabl Ltd | Medical Labs Memphis - MLM
Deal Size : Inapplicable
Deal Type : Inapplicable
